The Court of Appeal has ruled the Tribunal was “wrong to set aside the [CMA’s] decision” in relation to its investigation into phenytoin – a life-saving epilepsy drug.
Marketing
Tribunal was “wrong” to reject CMA phenytoin decision, says Court
Source: GOV.UK Competition Markets — UK Open Government Licence v3.0